OpenAI19:33Feature UpdatesOfficial Blog
OpenAI Releases GPT-Rosalind for Life Sciences
Accelerates hypothesis testing with scientific tools, expanding drug discovery options.
Key Points
- 1Superior in protein/chem reasoning & genomics.
- 2Available now in ChatGPT, Codex, API.
- 3Preview for Amgen, Moderna, etc.
- 4Aids shortening 10-15yr drug approval.
OpenAI introduced GPT-Rosalind, a frontier reasoning model for biology, drug discovery, and translational medicine in research preview. It excels in protein/chemical reasoning, genomics, and tool use, available via ChatGPT, Codex, and API for customers like Amgen and Moderna. Researchers can test hypotheses faster, shortening drug development timelines.